Immunotherapy after liver transplantation: Where are we now?

Initial experience with stereotactic body radiotherapy for intrahepatic hepatocellular carcinoma recurrence after liver transplantation

(2020) Kin Pan Au et al.   World Journal of Clinical Cases

Mammalian target of rapamycin inhibitors after post-transplant hepatocellular carcinoma recurrence: Is it too late?

(2020) Kin Pan Au et al.   World Journal of Gastrointestinal Surgery

LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)

(2019) T Yau et al.   ANNALS OF ONCOLOGY

Pembrolizumab for metastatic hepatocellular carcinoma following live donor liver transplantation: The silver bullet?

(2018) Ashwin Rammohan et al.   HEPATOLOGY

New NCCN Guidelines: Recognition and Management of Immunotherapy-Related Toxicity

(2018) John A. Thompson   Journal of the National Comprehensive Cancer Network

Immune checkpoint inhibitor therapy in a liver transplant recipient with a rare subtype of melanoma

(2018) James C. Kuo et al.   MELANOMA RESEARCH

Use of checkpoint inhibitors in liver transplant recipients

(2018) Stefan Munker et al.   United European Gastroenterology Journal

Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection

(2018) Martin Tio et al.   EUROPEAN JOURNAL OF CANCER

Multidisciplinary approach for post-liver transplant recurrence of hepatocellular carcinoma: A proposed management algorithm

(2018) Kin Pan Au et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Tapering of Immunosuppression and Sustained Treatment With Nivolumab in a Liver Transplant Recipient

(2017) Enrico N. De Toni et al.   GASTROENTEROLOGY

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

(2017) Anthony B El-Khoueiry et al.   LANCET

Fatal orthotopic liver transplant organ rejection induced by a checkpoint inhibitor in two patients with refractory, metastatic hepatocellular carcinoma

(2017) Brian D. Friend et al.   PEDIATRIC BLOOD & CANCER

Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation

(2016) Nicola de’Angelis et al.   Progress in Transplantation

Biopsy-proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal

(2016) Manuel Rodríguez-Perálvarez et al.   TRANSPLANT INTERNATIONAL

Dexamethasone enhances programmed cell death 1 (PD-1) expression during T cell activation: an insight into the optimum application of glucocorticoids in anti-cancer therapy

(2015) Kailin Xing et al.   BMC IMMUNOLOGY

Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis

(2015) Andrea Mancuso et al.   DIGESTIVE AND LIVER DISEASE

Administration of Ipilimumab to a Liver Transplant Recipient With Unresectable Metastatic Melanoma

(2015) Harsha A. Ranganath et al.   JOURNAL OF IMMUNOTHERAPY

Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

(2015) Rita E Morales et al.   Journal for ImmunoTherapy of Cancer

Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study

(2013) Carlo Sposito et al.   JOURNAL OF HEPATOLOGY

Late Acute Liver Allograft Rejection; A Study of Its Natural History and Graft Survival in the Current Era

(2013) Prem H. Thurairajah et al.   TRANSPLANTATION

Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation

(2011) Felix Bohne et al.   JOURNAL OF CLINICAL INVESTIGATION

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients

(2008) Marc Martínez-Llordella et al.   JOURNAL OF CLINICAL INVESTIGATION